Skip to main content

Incannex welcomes world-leading psychedelics experts to advisory board

ⓘ This article is third-party content and does not represent the views of this site. We make no guarantees regarding its accuracy or completeness.

Incannex Healthcare Ltd (ASX:IHL, NASDAQ: IXHL) director Peter Widdows tells Proactive the company has appointed three world-renowned psychedelic therapy and science experts to its Clarion Clinics Group Advisory Board. The Clarion Clinics Groups Pty Ltd is a collaborative venture between Incannex and three leading Australian psychedelics experts - Dr Paul Liknaitzky, Professor Suresh Sundram and Sean O’Carroll.

Contact Details

Proactive Investors

Jonathan Jackson

+61 413 713 744

Jonathan@proactiveinvestors.com

Report this content

If you believe this article contains misleading, harmful, or spam content, please let us know.

Report this article

Recent Quotes

View More
Symbol Price Change (%)
AMZN  259.53
-2.90 (-1.11%)
AAPL  340.97
+4.33 (1.29%)
AMD  594.24
-13.86 (-2.28%)
BAC  54.58
+0.26 (0.48%)
GOOG  348.97
+1.11 (0.32%)
META  742.96
+24.29 (3.38%)
MSFT  541.15
+6.08 (1.14%)
NVDA  226.32
-2.96 (-1.29%)
ORCL  137.39
-4.01 (-2.84%)
TSLA  378.03
-4.67 (-1.22%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.